FDA Gives Nod to New Breast Cancer Drug Philadelphia Inquirer FRIDAY, July 20 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved the use of the drug Afinitor (everolimus) for use by women with a particular form of advanced breast cancer. It's the first time that a drug from this class of ... |
